Showing results (331-340 of 2,735) with videos related to
Sort By:
Pageof 274
Expert Review of Neurotherapeutics|July 11, 2009
Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction?Leslie Citrome, Joshua T KantrowitzExpert Review of Neurotherapeutics|July 11, 2009
Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapyHans-Gert Bernstein, Johann Steiner, Bernhard BogertsExpert Review of Neurotherapeutics|August 14, 2009
Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disordersKeming Gao, David V Sheehan, Joseph R CalabreseExpert Review of Neurotherapeutics|August 14, 2009
Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's diseaseMakoto Naoi, Wakako MaruyamaExpert Review of Neurotherapeutics|February 13, 2009
Duloxetine in the treatment of generalized anxiety disorderSusan G Kornstein, James M Russell, Melissa E Spann, et al.Expert Review of Neurotherapeutics|February 13, 2009
Once-daily lamotrigine extended release for epilepsy managementSylvain Rheims, Philippe RyvlinExpert Review of Neurotherapeutics|February 13, 2009
CADASIL management or what to do when there is little one can doAlberto del Río-Espínola, Maite Mendióroz, Sophie Domingues-Montanari, et al.Expert Review of Neurotherapeutics|February 13, 2009
Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleusYvette A M Grimbergen, J William Langston, Raymund A C Roos, et al.Expert Review of Neurotherapeutics|April 7, 2009
Design and application of oncolytic HSV vectors for glioblastoma therapyPaola Grandi, Pierpaolo Peruzzi, Bonnie Reinhart, et al.Expert Review of Neurotherapeutics|April 7, 2009
Therapeutic strategies for inhibiting invasion in glioblastomaJan Drappatz, Andrew D Norden, Patrick Y WenPageof 274